Skip to content

Effect of Remimazolam on Emergence quality in Children FollowingTonsillectomy Surgery Under Sevoflurane Anesthesia

Effect of Remimazolam on Emergence quality in Children FollowingTonsillectomy Surgery Under Sevoflurane Anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105976
Enrollment
Unknown
Registered
2025-07-15
Start date
2025-07-15
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of Emergence from pediatric general anesthesia

Interventions

Experimental group:1.5-2.5 mg/kg propofol + 0.2 mg/kg remimazolam
Control group:1.5-2.5 mg/kg propofol + 0.2 ml/kg saline

Sponsors

Rinmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 12 Years

Inclusion criteria

Inclusion criteria: - 80 cases of children with elective surgery for proposed tonsillectomy in Rinmin Hospital of Wuhan University - The guardians of the children voluntarily signed the informed consent form. - Age of the children: 5-12 years old

Exclusion criteria

Exclusion criteria: - Congenital diseases such as heart disease, epilepsy, etc. - Bronchial disorders such as asthma - Perioperative allergy to any medication - The guardian of the child may waive the application at any time.

Design outcomes

Primary

MeasureTime frame
Agitation in children during emergence from general anesthesia: the PAED assessment scale;

Secondary

MeasureTime frame
Preoperative m-YPAS score;Duration from cessation of sevoflurane inhalation to tracheal tube removal;Total intraoperative dose of sufentanil and remifentanil;Duration of anesthesia and surgery;Timing of flumazenil administration and other antagonistic medications and doses;Recovery room remediation with propofol or remediation with analgesics situation;Heart rate, blood pressure, SpO2%, and MOAA/S at different time points;Cough rating, FLACC score at different time points;Adverse events within 30 min of extubation;

Countries

China

Contacts

Public ContactMeng Qingtao

Rinmin Hospital of Wuhan University

mengqingtao2018@126.com+86 15 170 270 6933

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026